Trial Details

COMPLETED
Basic Information
Clinical ID c960
Identifier NCT00194818
Trial Title Asacol Dosing Study for Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Asacol (mesalamine)
Participant Information
Sponsor University of Washington
City Seattle
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2025-06-03
Primary Completion Date 2025-08-07
Completion Date 2025-08-07